Institutional Ownership Karyopharm Therapeutics Inc. (KPTI)
This table provides information about the institutional ownership of Karyopharm Therapeutics Inc. (KPTI). We have compiled data on the 8 institutions that hold shares in the stock, with a total of 5.05 Million shares, which have been reported (via 13F filing form) to have a value of $26.8 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
4,169,788
shares
|
$22.1 Million
0.0% of portfolio
|
Q2 2024
Reduced 55.86%
|
|
|
Acadian Asset Management LLC
Boston, MA |
Feb 11, 2025 Q4 2024 |
342,847
shares
|
$1.82 Million
0.0% of portfolio
|
Q4 2024
Reduced 6.96%
|
|
|
Palo Alto Investors LP
Palo Alto, CA |
May 15, 2025 Q1 2025 |
324,032
shares
|
$1.72 Million
0.24% of portfolio
|
Q1 2025
Reduced 93.4%
|
|
|
Jefferies Group LLC
New York, NY |
Sep 21, 2023 Q3 2022 |
101,700
shares
|
$540,027
0.01% of portfolio
|
Q3 2022
Added 101600.0%
|
|
|
Wade G W & Inc
Wellesley, MA |
Feb 08, 2024 Q4 2023 |
45,140
shares
|
$239,693
0.0% of portfolio
|
Q3 2023
New holding
|
|
|
Sawtooth Solutions, LLC
|
Jan 29, 2024 Q4 2023 |
37,938
shares
|
$201,450
0.0% of portfolio
|
Q4 2023
New holding
|
|
|
Birchview Capital, LP
Burlington, VT |
May 15, 2025 Q1 2025 |
27,985
shares
|
$148,600
0.09% of portfolio
|
Q1 2025
Reduced 93.33%
|
|
|
Janiczek Wealth Management, LLC
|
Jul 25, 2024 Q2 2024 |
17
shares
|
$90
0.0% of portfolio
|
Q4 2023
New holding
|